- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/64 - Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
Patent holdings for IPC class C07D 277/64
Total number of patents in this class: 471
10-year publication summary
|
48
|
49
|
25
|
38
|
24
|
35
|
29
|
43
|
19
|
11
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4751 |
15 |
| Antabio SAS | 23 |
9 |
| Rutgers, The State University of New Jersey | 1972 |
9 |
| FUJIFILM Corporation | 30516 |
8 |
| The Regents of the University of Michigan | 4997 |
8 |
| Janssen Pharmaceutica N.V. | 3162 |
7 |
| CHDI Foundation, Inc. | 107 |
7 |
| The General Hospital Corporation | 4871 |
6 |
| Avexxin AS | 41 |
6 |
| EyePoint Pharmaceuticals, Inc. | 52 |
6 |
| Lighthouse Pharmaceuticals, Inc. | 11 |
6 |
| Eyepoint, Inc. | 49 |
6 |
| Genentech, Inc. | 4110 |
5 |
| Takeda Pharmaceutical Company Limited | 2710 |
5 |
| Agios Pharmaceuticals, Inc | 225 |
5 |
| Genzyme Corporation | 1367 |
5 |
| Gilead Sciences, Inc. | 2226 |
5 |
| King Faisal University | 933 |
5 |
| National Institutes for Quantum and Radiological Science and Technology | 101 |
5 |
| Sun Pharma Advanced Research Company Ltd. | 189 |
5 |
| Other owners | 338 |